Codix Bio Pharmaceutical Set to Launch Pioneering Factory in Ogun State This Weekend
Codix Bio Pharmaceutical Set to Launch Pioneering Factory in Ogun State This Weekend
A new pharmaceutical manufacturing plant dedicated to producing diagnostic and treatment kits for diabetes, hypertension, and cardiovascular diseases will be commissioned this weekend in @OGSG_Official. The facility, owned by Codix Bio Pharmaceutical Company, is strategically located along the Sagamu-Ijebu-Ode Expressway and marks a major milestone in Nigeria’s healthcare and manufacturing sectors.
During a courtesy visit to Governor @DapoAbiodunCON in Abeokuta, Codix CEO Mr. Sammy Ogunjimi emphasized the company’s shift from solely treatment to diagnostic innovation, citing a significant gap in accurate medical diagnosis in Nigeria. Codix, which began operations in 2008, was the first in Nigeria to establish national guidelines for diagnosing diabetes in 2009.
Mr. Ogunjimi revealed that the new facility will manufacture Rapid Diagnostic Test (RDT) kits for diseases such as HIV and malaria in partnership with the World Health Organization and SG Biosensor. He described the project as the first of its kind in Nigeria and the second largest RDT plant in sub-Saharan Africa.
Highlighting the lack of local test kit production—despite high usage across Africa—he called for increased African investment in healthcare manufacturing. He also announced plans for a second facility to support local production of generic medicines within the next 18 months.
Governor Abiodun praised the initiative, aligning it with the state’s goal of improving healthcare access and industrial development. He emphasized the need for capacity building in higher education to match the demands of emerging industries and commended Codix’s collaboration with Olabisi Onabanjo University Teaching Hospital.
The governor reaffirmed his administration’s commitment to strengthening primary healthcare, with over 100 centers already renovated and a goal of equipping one center per ward across the state.
He lauded Codix’s investment as a step toward achieving Nigeria’s goal of producing 70% of its pharmaceutical needs by 2030, stressing the importance of preparedness for future health crises.